Chinook Therapeutics Inc (NASDAQ:KDNY)

23.52
BATS BZX Real-Time Price
As of 3:57pm ET
 +0.90 / +3.98%
Today’s Change
11.16
Today|||52-Week Range
23.86
+44.21%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues3.1M2.8M3.9M4.9M
 
 
 
 
 
Depreciation And Amortization1.2M1.2M1.2M1.2M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses23.7M22.2M27.6M23.8M
 
 
 
 
 
Research And Development16.6M15.4M19.5M16.9M
 
 
 
 
 
Total Operating Expenses24.9M23.5M28.9M25.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.8M-20.7M-24.9M-20.1M
 
 
 
 
 
Extraordinary Charge-3.1M-7.3M0.000.00
 
 
 
Other Expenses21.0K-49.0K-19.0K-3.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-23.5M-26.7M-23.5M-18.6M
 
 
 
 
 
Income Taxes-385.0K-339.0K-35.0K-35.0K
 
 
 
 
 
Net Income-23.1M-26.3M-23.4M-18.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS79.1M79.4M79.7M80.0M
 
 
 
 
 
Shares To Calculate EPS Diluted79.1M79.4M79.7M80.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.29-$0.33-$0.29-$0.23
 
 
 
 
 
EPS Diluted-$0.29-$0.33-$0.29-$0.23